CytoMed Therapeutics GDTC
NASDAQ GDTC
$0.91 +0.00 (+0.00%)
As of: Oct 22, 2026 · 3:59 PM EDT

CytoMed Therapeutics (GDTC) Prepaid Assets (2025 - 2026)

Updated

Analysis

CytoMed Therapeutics (GDTC) Prepaid Assets (2025 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn
10 CytoMed Therapeutics 10.46 Mn 855,548.76 -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 319,545.00
Dec 31, 2025 338,796.00
API Access

CytoMed Therapeutics Prepaid Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=prepaid-assets&ticker=GDTC&period=max&api_key=YOUR_API_KEY